Scientists at UNIST have developed “NK cell-engaging nanodrones” capable of targeting and eliminating cancer cells. The nanodrones, called NKeNDs, use nanoparticles and proteins to trigger natural killer (NK) cells, a type of immune cell, to attack cancer cells in the body. The technology has shown potential in selectively treating challenging types of cancers, significantly suppressing tumour growth without side effects.
Dispersed responsibility, lack of asset inventory is causing gaps in medical device cybersecurity
Witnesses at a House hearing on medical device cybersecurity highlighted the need for better tracking of devices and their vulnerability to cyber threats. They noted
